http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51b6fee140bc0c12fd4380234c09fbac
Outgoing Links
Predicate | Object |
---|---|
family-name | Hazlehurst |
name | Lori A Hazlehurst Lori A. Hazlehurst |
given-name | Lori A Lori A. |
organization-name | Department of Pharmaceutical Sciences, West Virginia University Cancer Institute Morgantown, WV, USA. 1Molecular Oncology Program,; 2Experimental Therapeutics Program,; 6Department of Molecular Medicine, University of South Florida, Tampa, Florida From the H. Lee. Moffitt Cancer Center, University of South Florida, Tampa, FL; and the Arizona Cancer Center, University of Arizona, Tucson, AZ. 1Experimental Therapeutics Program and Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida and Molecular Oncology Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida Authors' Affiliation: Department of Experimental Therapeutics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 1Department of Interdisciplinary Oncology and Experimental Therapeutics Program and Experimental Therapeutics and Oncologic Sciences Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida Modulation Therapeutics Incorporated Morgantown West Virginia USA; Tumor Biology Department H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA; Department of Pharmaceutical Sciences West Virginia University Health Sciences Center Morgantown West Virginia USA From the Department of Interdisciplinary Oncology and Experimental Therapeutics Program, Biostatistics Core Facility, H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida, Tampa, FL. Department of Interdisciplinary Oncology and Experimental Therapeutics Program, H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida, Tampa; From the Department of Interdisciplinary Oncology and Clinical Investigations Program and the Biostatistical Department, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL. Authors' Affiliations: 1Molecular Oncology Program; 2Hematology Malignancies Program; 3Drug Discovery Department, Moffitt Cancer Center; 4Cancer Biology Program; 5Molecular Pharmacology and Physiology Program; 6Department of Chemistry, University of South Florida, Tampa, Florida; and 7Department of Cell Biology and Anatomy, University of Arizona, Tucson, Arizona; Authors' Affiliations: 1Molecular Oncology Program; 2Hematology Malignancies Program; 3Drug Discovery Department, Moffitt Cancer Center; 4Cancer Biology Program; 5Molecular Pharmacology and Physiology Program; 6Department of Chemistry, University of South Florida, Tampa, Florida; and 7Department of Cell Biology and Anatomy, University of Arizona, Tucson, Arizona; Authors' Affiliations: 1Molecular Oncology Program; 2Hematology Malignancies Program; 3Drug Discovery Department, Moffitt Cancer Center; 4Cancer Biology Program; 5Molecular Pharmacology and Physiology Program; 6Department of Chemistry, University of South Florida, Tampa, Florida; and 7Department of Cell Biology and Anatomy, University of Arizona, Tucson, Arizona; Authors' Affiliations: 1Molecular Oncology Program; 2Hematology Malignancies Program; 3Drug Discovery Department, Moffitt Cancer Center; 4Cancer Biology Program; 5Molecular Pharmacology and Physiology Program; 6Department of Chemistry, University of South Florida, Tampa, Florida; and 7Department of Cell Biology and Anatomy, University of Arizona, Tucson, Arizona 1Cancer Biology Ph.D. Program, University of South Florida; Departments of 2Experimental Therapeutics and 3Immunology, 4Biostatistics Core, and 5Bone Marrow Transplantation Program, H. Lee Moffitt Cancer Center, Tampa, Florida Department of Interdisciplinary Oncology, Experimental Therapeutics and Drug Discovery Programs, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. Molecular Oncology Department, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, Florida 33612, United States Hematopoietic Malignancy and Transplantation Program, West Virginia University, Morgantown, WV, USA Cancer Cell Biology, West Virginia University , Morgantown, WV , USA; Pharmaceutical Sciences, West Virginia University , Morgantown, WV , USA Authors' Affiliations: 1Molecular Pharmacology and Physiology Program; 2Department of Chemistry, University of South Florida; 3Molecular Oncology Program; 4Department of Drug Discovery, H. Lee Moffitt Cancer Center and Research Institute; and 5Modulation Therapeutics Inc., Tampa, Florida Department of Pharmaceutical Sciences School of Pharmacy West Virginia University Morgantown West Virginia 26506 Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, at The University of South Florida, 12902 Magnolia Drive, Tampa, FL 33612, USA. 1Molecular Oncology, 2Immunology, 3Drug Discovery, and 4Experimental Therapeutics Programs, Moffitt Cancer Center, Tampa, Florida; 5Department of Cell Biology and Anatomy, University of Arizona, Tucson, Arizona; and 6Internal Medicine, University of California Davis, Davis, California; 1Molecular Oncology, 2Immunology, 3Drug Discovery, and 4Experimental Therapeutics Programs, Moffitt Cancer Center, Tampa, Florida; 5Department of Cell Biology and Anatomy, University of Arizona, Tucson, Arizona; and 6Internal Medicine, University of California Davis, Davis, California |
Incoming Links
Total number of triples: 74.